Cellesce retweeted
Illustration of three random fates of a (blue) crypt #stemcell. The first one is almost immediately unlucky and pushed out by a neighbouring stem cell. The second and third do better. The latter eventually even overtakes the entire crypt. But all by chance: Neutral competition
Cellesce retweeted
We spoke with Dr Mark Treherne, CEO of @Cellesce - one of our CRO partners that has developed patented bioprocessing technology for #organoid expansion. Read the interview to hear his views on the #biopharma market and upcoming #technologies bit.ly/2NHbU1U
Cellesce retweeted
Today's #BioLeaders2019 interview is with Mark Treherne. Mark has worked with many early-stage #biotech companies from foundation through to trade sale. Most recently, he joined Cellesce Ltd as Chief Executive.
Read Mark's interview here: pir-intl.com/mark-treherne/
Cellesce retweeted
Mark Treherne, CEO of @Cellesce talks to us about his career in drug discovery, spanning academia, big Pharma, one of the UK's first CROs, biotech and government.
Head to anchor.fm/careers-in-discove… to listen to the interview on the Careers in Discovery podcast.
#Careers #podcast
Cellesce retweeted
an image providing the various cell types of the small intestinal epithelium. Note that enteroendocrine cells come in many flavours. The crypt base columnar cell was first described -and proposed to be the stem cell- by Hazel Chang and J.P. Leblond. More about the latter later
Cellesce retweeted
Today I'm submitting a Parliamentary motion calling on the Prime Minister to apologise for her offensive remarks yesterday saying that EU citizens in the UK had "jumped the queue". Her words have caused great offence to EU citizens here. They deserve better & I demand better.
Cellesce retweeted
The countdown is on to EORTC-NCI-AACR 2018! During the event, we will be hosting our Pre-Clinical Oncology Showcase, where representatives from @Cellesce, Ocello & EPO Berlin will be discussing 3D organoid technology. Secure your place now: eventbrite.com/e/pre-clinica… #AACR #organoid
Cellesce retweeted
Join Repositive and speakers from @Cellesce, Ocello & EPO Berlin at our Pre-Clinical Oncology Showcase at EORTC-NCI-AACR 2018 to learn more about 3D organoid technology – tickets are limited so sign up now! eventbrite.com/e/pre-clinica…
Cellesce retweeted
.@cellesce - 24hrs on and I’m still letting the news sink in. Thank you to the massive positive energies of the entire team - Liz Fraser @Mairian_Thomas @TrevorCDale @MarianneJEllis Mark Treherne & our collaborators 😋
#innovateuk #funding #organoidtechnologies
Cellesce retweeted
Replying to @DrMairianThomas @Cellesce
Congratulations Mairi!! Very well deserved 👏👏 #organoidqueen
Cellesce retweeted
Today, #organoids are revolutionizing the patient-specific screening of Orkambi for #cysticfibrosis treatment. How could they impact your research tomorrow? Watch the webinar: ow.ly/VuyB30iHw7D
Cellesce retweeted
#BioWales2018 Innovation Zone The Innovation Zone, situated in the Ffresh Bar will offer a vast display of SME’s in Biomedicine. A number workshops and presentations will be scheduled throughout the day @Arkivum @egtechnology @WWIC_Wales @Cellesce biowales.com/en/about/
Cellesce retweeted
We work with you to help your business grow! ow.ly/ZKXd30h5ZC6
Cellesce retweeted
The number of cell and gene therapy jobs in the UK has more than doubled since 2012 #industrygrowth #annualreview - ow.ly/yoOz30gkrAT
Cellesce retweeted
'We have world leading researchers helping guide the next generation & fostering innovation,' - Carl Griffiths ow.ly/wW8v30bdFG9
Cellesce retweeted
Great to see the continued growth and success of @Cellesce, the product of research collaboration between GW4's @UniofBath and @cardiffuni xitter.cf/FinanceWales/status/85…
Cardiff life science company @Cellesce secures six-figure funding round to continue organoid research ow.ly/gEm530aWFip
Cellesce retweeted
Cardiff life science company @Cellesce secures six-figure funding round to continue organoid research ow.ly/gEm530aWFip
Cellesce retweeted
Cardiff life science company @Cellesce secures six-figure funding round to continue organoid research ow.ly/gEm530aWFip




























